Bioelectronics Corp

Medical Devices

Prices are adjusted according to historical splits.

Bioelectronics Corp Stock Price


Today's Low:
Today's High:
Open Price:
52W Low:
52W High:
Prev. Close:

Company Statistics

Market Cap.:
$12.35 million
Book Value:
Revenue TTM:
$1.61 million
Operating Margin TTM:
Gross Profit TTM:
Profit Margin:
Return on Assets TTM:
Return on Equity TTM:

Company Profile

Bioelectronics Corp had its IPO on under the ticker symbol BIEL.

The company operates in the Healthcare sector and Medical Devices industry. Bioelectronics Corp has a staff strength of 0 employees.

Stock update

Shares of Bioelectronics Corp opened at $0 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0 - $0, and closed at $0.

This is a -25% slip from the previous day's closing price.

A total volume of 29,396,740 shares were traded at the close of the day’s session.

In the last one week, shares of Bioelectronics Corp have slipped by -40%.

Bioelectronics Corp's Key Ratios

Bioelectronics Corp has a market cap of $12.35 million, indicating a price to book ratio of 0 and a price to sales ratio of 30.732.

In the last 12-months Bioelectronics Corp’s revenue was $1.61 million with a gross profit of $795532 and an EBITDA of $-1364449. The EBITDA ratio measures Bioelectronics Corp's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Bioelectronics Corp’s operating margin was -8.52% while its return on assets stood at -33.67% with a return of equity of 0%.

In Q4, Bioelectronics Corp’s quarterly earnings growth was a positive 0% while revenue growth was a negative 65.1%.

Bioelectronics Corp’s PE and PEG Ratio

Forward PE
Trailing PE

Its diluted EPS in the last 12-months stands at $0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Bioelectronics Corp’s profitability.

Bioelectronics Corp stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 30.732.

Bioelectronics Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
Total Liabilities
$5.93 million
Operating Cash Flow
Capital Expenditure
Dividend Payout Ratio

Bioelectronics Corp ended 2024 with $0 in total assets and $0 in total liabilities. Its intangible assets were valued at $0 while shareholder equity stood at $0.

Bioelectronics Corp ended 2024 with $0 in deferred long-term liabilities, $5.93 million in other current liabilities, 24378829.00 in common stock, $-38306477.00 in retained earnings and $0 in goodwill. Its cash balance stood at $0 and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.

Bioelectronics Corp’s total current assets stands at $83886.00 while long-term investments were $0 and short-term investments were $0. Its net receivables were $57699.00 compared to accounts payable of $647844.00 and inventory worth $25262.00.

In 2024, Bioelectronics Corp's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Bioelectronics Corp paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
52-Week High
52-Week Low
Analyst Target Price

Bioelectronics Corp stock is currently trading at $0 per share. It touched a 52-week high of $0.0012 and a 52-week low of $0.0012. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0.4% are held by institutions.

Frequently Asked Questions About Bioelectronics Corp

The stock symbol (also called stock or share ticker) of Bioelectronics Corp is BIEL

The IPO of Bioelectronics Corp took place on

Similar Industry Stocks (Medical Devices)

Last Price
Aarons Inc (AAN)

Most Active

Last Price
Amyris Inc (AMRS)
Humbl Inc (HMBL)

Top Gainers

Last Price
Latch Inc (LTCHW)

Top Losers

Last Price


BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. Its products include ActiPatch, a musculoskeletal pain therapy; Allay, a menstrual pain therapy; and Smart Insole, a heel pain therapy. The company also offers RecoveryRx, a medical device that provides pain management therapy for medical professionals; and HealFast, a drug-free therapy for horses, cats, and dogs that reduces swelling and pain, as well as heals muscle and tendon injuries, sores, and incisions. It sells its products to wholesale distributors, hospitals and clinics, and consumers. The company was incorporated in 2000 and is headquartered in Frederick, Maryland.


4539 Metropolitan Court, Frederick, MD, United States, 21704